The number of people with susceptibility test result for rifampicin in Guatemala
Guatemala: The number of people with susceptibility test result for rifampicin was 2,022 in 2021. ▲ Rising
Latest (2021)
2,022
Change on year
up 196.5%
World rank
46th
of 155 countries
All-time high
2,022
in 2021
All-time low
682
in 2020
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Guatemala, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for the number of people with susceptibility test result for rifampicin in Guatemala is 2,022, measured in 2021. That is the highest value across all 5 years on record.
The figure is up 196.5% on the previous year and up 137.6% over five years.
Guatemala ranks 46th of 155 countries on this measure, in the middle of the range.
The number of people with susceptibility test result for rifampicin in Guatemala, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 851 | — |
| 2018 | 732 | -14.0% |
| 2019 | 1,795 | +145.2% |
| 2020 | 682 | -62.0% |
| 2021 | 2,022 | +196.5% |
Guatemala compared with similar countries
- Guatemala's 2,022 is above the median for upper middle income countries, which is 880, 2.3× the median. (46 countries reporting)
- Guatemala's 2,022 is above the median for Latin America & Caribbean, which is 406.5, 5.0× the median. (26 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 1,126 | 732 | 1,795 | 3 |
| 2020s | 1,352 | 682 | 2,022 | 2 |
Countries ranked near Guatemala
- 43 Poland 2,415 compare
- 44 Argentina 2,309 compare
- 45 Hong Kong, China 2,181 compare
- 47 Congo 2,015 compare
- 48 Guinea-Bissau 1,934 compare
- 49 Kyrgyzstan 1,932 compare
More health data for Guatemala
- Un projection of annual infant deaths, annual growth rate -1.92 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7968 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,202 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1,022 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -0.4059 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0487 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.3488 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Guatemala?
- The number of people with susceptibility test result for rifampicin in Guatemala was 2,022 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Guatemala?
- The highest recorded value was 2,022 in 2021.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Guatemala?
- The lowest recorded value was 682 in 2020.
- How does Guatemala rank for the number of people with susceptibility test result for rifampicin?
- Guatemala ranks 46th out of 155 countries with data for 2021.
- Where does this Guatemala data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).